In patients with ischemic stroke and concurrent nonvalvular atrial fibrillation and ASCVD, adding an antiplatelet agent to anticoagulant therapy offered no net clinical benefit over anticoagulant monotherapy. https://t.co/ZNZv1yo0wN
Original Article: Early Withdrawal of Aspirin after PCI in Acute Coronary Syndromes (NEO-MINDSET trial) https://t.co/IA8PpmkF2U
Editorial: Discontinuation of Aspirin in Acute Coronary Syndromes Treated with Coronary-Artery Stents https://t.co/l9WMZhe3u6
#Cardiology
For scar-related VTs, the exit predicted from a vector-based #QRS algorithm often differs from the location where ablation terminates the VT. This is an important consideration for use of the QRS to guide VT ablation strategies. https://t.co/WYqqJr3cTI
#JACCCEP#epAblation
Programmed ventricular stimulation for risk stratification in patients with myocardial scarring and mildly reduced or preserved ejection fraction #OpenAccess
https://t.co/Iu0WhUzCx5
OCEAN just published in NEJM.
In AF patients >1 yr after successful ablation, rivaroxaban did not reduce stroke/systemic embolism/new covert infarcts vs aspirin (0.31 vs 0.66 events/100 pt-yrs; P=0.28). Bleeding higher with rivaroxaban (1.6% vs 0.6%).
https://t.co/AVZoOyhTqO
Aspirin, cardiovascular events, and major bleeding in older adults: extended follow-up of the ASPREE trial: @ESC_Journals
🥸Aspirin for primary prevention for older pts = MACE!
👇👇👇👇
Pulmonary vein isolation (PVI) in persistent AF: not sufficient and possibly not always necessary. Durable PVI increases freedom from AF only in paroxysmal but not in persistent AF @Tardu_Oezkartal@Mbergonti#AHAJournals#Epeeps
https://t.co/Hkr7096rXW
New research reveals that atrial fibrillation impairs brain glymphatic function, which is crucial for clearing toxins and maintaining cognitive health.
Read more in #EHJ.
https://t.co/VUsdqLM352
#AF#cognitive#cardiotwitter@ESC_Journals@escardio
🚨Latest #FreeRead Article in
@JICE_EP
Correlation Between Diagnosis-to-Ablation Time & Atrial Fibrillation Recurrence: a Systematic review & Meta-analysis
🧐📖https://t.co/7HJ4xmrEOV
by Muhammad Arslan Ul Hassan, Sana Mushtaq, Tao Li, Zhen Yang, Abdul Rehman & Al-qaisi Mohammed Abdulkarem
#EPeeps
PVI using thermal ablation energy results in significant sustained changes in the heart rate parameters related to autonomic function. These changes are independent of ablation technology employed & are associated w/ procedural success https://t.co/oW4TqeBjwo
#JACCCEP#AFib
#JACCCEP multicenter RCT shows that CSI in addition to PVI & roofline ablation for first-time procedures in a small population of pts w/ paroxysmal & early persistent #AFib does not reduce AF recurrence after 2 yrs follow-up https://t.co/R4HPXJP0uj
@JonathanAriya@PrashSanders
RF ablation of persistent A fib by PVI with or without posterior wall isolation: no difference at 3yrs with 0% AF burden in both groups https://t.co/4iiBLkTZRY @escardio@JonKalmanEP@PrashSanders#CAPLA
In a Japanese large-scale multicenter retrospective study, early timing of #cryoablation from first diagnosis of #AFib ⬇️risk of recurrence in patients w/ #heartfailure, which may help improve clinical management. https://t.co/YRRJIVaR9U
#JACCAsia#ACCIntl